All News

Found 16,438 articles

• Neurocrine Biosciences, Inc. Announces The Appointment Of Adrian Adams To The Board Of Directors

  12/8/2005

• Galapagos Extends Services Deal With Amgen

  12/7/2005

• Xenogen Corporation Announces Extension Of Global Licensing Agreement With Novartis Corporation

  12/7/2005

• The Day In Review: Big Pharma Licenses Drugs From Biotech

  12/7/2005

• Novartis Pharmaceuticals Corporation And Astex Therapeutics Ink $520 Million Cancer Drug Deal

  12/6/2005

• Clarus Ventures, A Life Sciences Venture Capital Firm, Announces Closing Of $500 Million First Fund

  12/6/2005

• Chiron Corporation Release: U.S. Federal Trade Commission Approves Early Termination Of Hart-Scott-Rodino Waiting Period

  12/6/2005

• QLT Inc. To Host Conference Call To Discuss Strategic Update

  12/6/2005

• Genzyme Corporation Launches Colorectal Cancer Test To Determine Appropriate Camptosar(R) Dosage

  12/6/2005

• Tanox, Inc. Co-Founder To Step Down As President, CEO

  12/5/2005

• Eisai Inc. Release: Data Evaluating The Safety And Efficacy Of Anti-epileptic Drug Rufinamide Presented At American Epilepsy Society

  12/5/2005

• Idenix Pharmaceuticals, Inc. Provides Update On Clinical Development Program For Valopicitabine (NM283) For The Treatment Of Hepatitis C

  12/2/2005

• Lentigen Corporation Appoints Experienced Management Team

  12/2/2005

• OncoMed Pharmaceuticals, Inc. Appoints Paul J. Hastings President And Chief Executive Officer

  12/1/2005

• Sirtris Pharmaceuticals Hires Peter Elliott As SVP, Head Of Development

  11/30/2005

• Novartis Corporation Issues Breast Cancer Drug Warning

  11/29/2005

• Novartis Corporation Sells Dietary Food Unit For $259 Million

  11/29/2005

• FDA Approves Novartis Corporation's Trileptal(R) As Adjunctive Therapy In Children As Young As Two

  11/28/2005

• Anadys Pharmaceuticals, Inc. To Present At Lazard Capital Markets Annual Life Sciences Conference

  11/23/2005

• FDA Wants Stronger Asthma Drug Warnings On GlaxoSmithKline's Advair, Serevent And Novartis Pharma AG's Foradil

  11/21/2005